Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials

Matthew P. Deek , MD; Kim Van der Eecken, MD, PhD; Philip Sutera , MD; Rebecca A. Deek, MS; Valérie Fonteyne, MD, PhD; Adrianna A. Mendes, MD; Karel Decaestecker, MD, PhD; Ana Ponce Kiess, MD, PhD; Nicolaas Lumen, MD, PhD; Ryan Phillips , MD, PhD; Aurélie De Bruycker , MD; Mark Mishra, MD; Zaker Rana , MD; Jason Molitoris , MD, PhD; Bieke Lambert, MD; Louke Delrue, MD; Hailun Wang , PhD; Kathryn Lowe, BS; Sofie Verbeke , MD, PhD; Jo Van Dorpe , MD, PhD; Renée Bultijnck , PhD; Geert Villeirs , MD; Kathia De Man, MD; Filip Ameye, MD; Daniel Y. Song, MD; Theodore DeWeese, MD; Channing J. Paller , MD; Felix Y. Feng , MD; Alexander Wyatt, PhD; Kenneth J. Pienta , MD15; Maximillian Diehn , MD, PhD; Soren M. Bentzen , PhD, DMsc; Steven Joniau , MD, PhD; Friedl Vanhaverbeke, MD; Gert De Meerleer, MD23; Emmanuel S. Antonarakis , MD; Tamara L. Lotan, MD; Alejandro Berlin , MD; Shankar Siva , MD, PhD; Piet Ost , MD, PhD27; and Phuoc T. Tran , MD, PhD

Journal of Clinical Oncology

Link all’abstract

© 2022 by American Society of Clinical Oncology